Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
BA.5.2.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.80NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.37.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used